Identifying Barriers to Cellular Therapy
Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD
What's the purpose of the trial?
This is an observational study that will include both participants with relapsed/refractory Multiple Myeloma and their doctors.
Accepting patients
Participating Centers
There are 7 centers participating in this trial. Enter a location below to find the closest center.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Accepting patients
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.